Stay updated with breaking news from Dydo Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2023 Earnings Call Transcript February 29, 2024 Catalyst Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the Catalyst Pharmaceuticals Inc. Fourth Quarter and Full Year 2023 Financial Results Conference […]
Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022
29.02.2024 - Achieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022 Achieved Record Fourth Quarter 2023 Total Revenues of $110.6 Million, an 82.0% Increase Compared to Fourth Quarter 2022 Reported 2023 GAAP ...
CORAL GABLES, Fla., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") CPRX, a commercial-stage biopharmaceutical company focused…
Third Quarter 2023 Total Net Revenues of $102.7 Million, a 79.4% Increase YOY Third Quarter 2023 GAAP Net Loss per Share of $ Diluted, Impacted by an $81.5 Million One Time Non-Recurring...